Millennium Management’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,118,328
Closed -$37.1M 7401
2022
Q4
$37.1M Buy
1,118,328
+327,429
+41% +$10.5M 0.02% 960
2022
Q3
$24.9M Buy
790,899
+733,435
+1,276% +$23.7M 0.01% 1143
2022
Q2
$1.75M Buy
+57,464
New +$1.55M ﹤0.01% 3845
2022
Q1
Sell
-30,434
Closed -$621K 7912
2021
Q4
$621K Sell
30,434
-241,108
-89% -$4.62M ﹤0.01% 4855
2021
Q3
$5.22M Sell
271,542
-129,745
-32% -$2.59M ﹤0.01% 2813
2021
Q2
$8.9M Buy
401,287
+64,056
+19% +$1.36M 0.01% 2059
2021
Q1
$8.85M Sell
337,231
-96,757
-22% -$2.3M 0.01% 1915
2020
Q4
$8.11M Buy
433,988
+418,838
+2,765% +$7.82M 0.01% 1975
2020
Q3
$257 Sell
15,150
-666,074
-98% -$12.9M ﹤0.01% 3936
2020
Q2
$15.9M Sell
681,224
-487,161
-42% -$7.06M 0.02% 896
2020
Q1
$9.81M Buy
1,168,385
+1,005,374
+617% +$8.46M 0.02% 869
2019
Q4
$1.59M Buy
163,011
+133,897
+460% +$1.26M ﹤0.01% 2745
2019
Q3
$276K Buy
+29,114
New +$307K ﹤0.01% 3606
2019
Q2
Sell
-27,456
Closed -$484K 4626
2019
Q1
$484K Buy
27,456
+2,626
+11% +$43.7K ﹤0.01% 3290
2018
Q4
$431K Sell
24,830
-251,193
-91% -$4.28M ﹤0.01% 3047
2018
Q3
$4.11M Sell
276,023
-167,745
-38% -$2.6M 0.01% 1951
2018
Q2
$7.06M Sell
443,768
-395,841
-47% -$5.9M 0.01% 1554
2018
Q1
$11.9M Sell
839,609
-294,156
-26% -$4.35M 0.02% 1224
2017
Q4
$15.9M Buy
1,133,765
+402,430
+55% +$5.89M 0.02% 1047
2017
Q3
$10.5M Buy
731,335
+395,802
+118% +$5.65M 0.02% 1210
2017
Q2
$5.29M Buy
+335,533
New +$4.83M 0.01% 1468
2016
Q4
Sell
-30,648
Closed -$591K 3855
2016
Q3
$591K Buy
+30,648
New +$600K ﹤0.01% 2520
2015
Q4
Sell
-207,015
Closed -$3.54M 3868
2015
Q3
$3.54M Sell
207,015
-153,553
-43% -$2.81M 0.01% 1537
2015
Q2
$6.72M Sell
360,568
-107,889
-23% -$2M 0.01% 1207
2015
Q1
$8.94M Sell
468,457
-110,126
-19% -$2.04M 0.02% 1080
2014
Q4
$9.52M Buy
578,583
+270,217
+88% +$4.64M 0.02% 1017
2014
Q3
$5.46M Buy
308,366
+191,640
+164% +$3.77M 0.01% 1241
2014
Q2
$2.41M Buy
116,726
+70,993
+155% +$1.46M 0.01% 1651
2014
Q1
$997K Buy
45,733
+35,073
+329% +$804K ﹤0.01% 2228
2013
Q4
$283K Sell
10,660
-22,943
-68% -$564K ﹤0.01% 3076
2013
Q3
$794K Buy
33,603
+8,446
+34% +$197K ﹤0.01% 2264
2013
Q2
$541K Buy
+25,157
New +$543K ﹤0.01% 2295

Other funds holding VIVO

Millennium Management's VIVO Position: Q1 2023 in Review

Millennium Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,118,328 shares — an estimated $37.1M sold.

Millennium Management first reported a position in VIVO in Q2 2013 and held it in 32 quarters. The position peaked at $37.1M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Millennium Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 1,118,328 Meridian Bioscience Inc shares in Q1 2023, an estimated $37.1M.
  • Millennium Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 32 quarters.
  • Millennium Management's Meridian Bioscience Inc position peaked at $37.1M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.